CMO Purchases 932.4K Shares of This Major Medical Company

Galera Therapeutics Inc. (NASDAQ: GRTX), a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for transformational improvements in cancer treatment, has recently seen a significant insider purchase. Yair Schneid, 10% owner of Galera, bought 932.4k shares at $0.18 each. This move is intriguing and deserves a closer look. $Galera Therapeutics (GRTX.US)$